ClinConnect ClinConnect Logo
Search / Trial NCT03059472

Strong Hearts for New York: A Rural Heart Disease Prevention Study

Launched by CORNELL UNIVERSITY · Feb 16, 2017

Trial Information

Current as of August 02, 2025

Completed

Keywords

Physical Activity Nutrition Social Network Civic Engagement

ClinConnect Summary

There are notable cardiovascular disease (CVD) disparities among people living in rural settings, particularly medically underserved rural areas. Complex factors such as socioeconomic disadvantage, social and cultural dynamics, geographic distances/barriers, and limited access to healthcare, healthy foods, and/or physical activity opportunities contribute to the issue. The objective of Strong Hearts, Healthy Communities (SHHC) is to reduce rural CVD disparities through civic engagement and implementation of a community-based intervention in 11 underserved New York communities. SHHC builds u...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Body Mass Index (BMI) greater than or equal to 25
  • If BMI is less than 30, not currently physically active
  • Blood pressure is less than 160/100 mm Hg
  • Heart rate is between 60-100 bpm
  • English-speaking
  • Able and willing to obtain physician's approval to participate in intervention starting either in March 2017 or September 2017
  • Willing to participate in assessment activities
  • Willing to make a firm commitment to participate in intervention starting either in Spring or Fall 2017
  • Exclusion Criteria:
  • BMI less than 25
  • If BMI is less than 30, currently physically active
  • Untreated hypertension
  • Heart rate lower than 60 or higher than 100 bpm
  • Non-English speaking
  • Not able or willing to obtain physician's approval to participate
  • Not interested or willing to participate in assessment activities
  • Not able or willing to make a firm commitment to participate in intervention starting either in Spring or Fall 2017

About Cornell University

Cornell University is a prestigious Ivy League institution renowned for its commitment to academic excellence and innovative research. As a clinical trial sponsor, Cornell leverages its interdisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The university fosters collaboration among leading researchers, clinicians, and students, aiming to translate scientific discoveries into effective therapies. Cornell's rigorous adherence to ethical standards and regulatory compliance ensures the integrity and safety of its clinical trials, contributing to the advancement of healthcare and the well-being of communities.

Locations

Clyde, New York, United States

Cobleskill, New York, United States

Cooperstown, New York, United States

Dolgeville, New York, United States

Hamilton, New York, United States

Hartwick, New York, United States

Herkimer, New York, United States

Ithaca, New York, United States

Ithaca, New York, United States

Milford, New York, United States

Morrisville, New York, United States

Newark, New York, United States

Sharon Springs, New York, United States

Patients applied

0 patients applied

Trial Officials

Rebecca Seguin, PhD

Principal Investigator

Cornell University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials